Individual provider · Type 1 NPI
Milena Elimelakh, MD
Medical Oncology Physician · Hollywood, FL
NPI number
1679609689
Active
Practice location
3850 Hollywood Blvd
Hollywood, FL 33021-6748
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Medical Oncology Physician Primary | 207RX0202X | ME144015 (FL) |
Medical Oncology Physician: An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
23 other providers at this address
- Cancer Cure PAHematology & Oncology Physician Hollywood, FL NPI 1447508502
- Chris William Akins MD PAThoracic Surgery (Cardiothoracic Vascular Surgery) Physician Hollywood, FL NPI 1881714459
- Frederic L Bushkin MD PASurgery Physician Hollywood, FL NPI 1023262391
- Jay S. Chandar, Md, PAPediatric Cardiology Physician Hollywood, FL NPI 1003168451
- Lane Eye Center, P.a.Ophthalmology Physician Hollywood, FL NPI 1609064500
- Ney R F Alves MD P AHematology & Oncology Physician Hollywood, FL NPI 1730416637
- Ronald D Smith and Eduardo Weiss MD PASpecialist Hollywood, FL NPI 1790735710
- Sholomo J Lanes MD PAVascular Surgery Physician Hollywood, FL NPI 1790229912
- South Broward Vascular Associates LLCVascular Surgery Physician Hollywood, FL NPI 1215165121
- South Florida Cardiothoracic and Vascular Surgery PLThoracic Surgery (Cardiothoracic Vascular Surgery) Physician Hollywood, FL NPI 1851450712
- Urology Associates, PASpecialist Hollywood, FL NPI 1578881785
- Adel Eltantawy, PharmD, BCOPOncology Pharmacist Hollywood, FL NPI 1386084093
Other medical oncology physician providers in Hollywood
About NPI 1679609689
Milena Elimelakh, MD's National Provider Identifier is 1679609689, issued on Feb 26, 2007. The primary taxonomy on file is Medical Oncology Physician (207RX0202X), and the practice location is in Hollywood, FL. The record was last updated on Aug 4, 2022.